Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Sell
9
NPCE Quote, Financials, Valuation and Earnings
Last price:
$10.39
Seasonality move
:
-33.68%
Day range:
$9.89 - $10.75
52-week range:
$5.45 - $15.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.80x
P/B ratio:
42.34x
Volume:
102.1K
Avg. volume:
228.3K
1-year change:
-28.16%
Market cap:
$339.3M
Revenue:
$79.9M
EPS (TTM):
-$0.95
Earnings Data
Next earnings date for NPCE
May 08
2025
Most recent earnings per share
-$0.18
Beat by $0.04
(Mar 4/2025)
Consensus Estimate
-$0.22
(Mar 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
NPCE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $22.7M | -- | -- | -$0.22 | -- |
| 05/08/2025 | Q1 | $21.8M | -- | -- | -$0.24 | -- |
| 03/04/2025 | Q4 | $21.1M | $21.5M | -$0.18 | -$0.22 | $0.04 |
| 11/12/2024 | Q3 | $19.1M | $21.1M | -$0.19 | -$0.27 | $0.08 |
| 08/13/2024 | Q2 | $18.3M | $19.3M | -$0.26 | -$0.30 | $0.04 |
| 05/08/2024 | Q1 | $17.3M | $18.1M | -$0.32 | -$0.32 | $0.00 |
| 03/05/2024 | Q4 | $17.7M | $18M | -$0.22 | -$0.32 | $0.10 |
| 11/06/2023 | Q3 | -- | -- | -$0.28 | -$0.41 | $0.13 |
| 08/08/2023 | Q2 | -- | -- | -$0.36 | -$0.46 | $0.10 |
| 05/04/2023 | Q1 | -- | -- | -$0.41 | -$0.44 | $0.03 |
| 03/02/2023 | Q4 | -- | -- | -$0.45 | -$0.50 | $0.05 |
| 11/08/2022 | Q3 | -- | -- | -$0.48 | -$0.53 | $0.05 |
| 08/11/2022 | Q2 | -- | -- | -$0.52 | -$0.44 | -$0.08 |
| 05/12/2022 | Q1 | -- | -- | -$0.47 | -$0.44 | -$0.03 |
| 03/10/2022 | Q4 | -- | -- | -$0.44 | -$0.33 | -$0.11 |
| 11/10/2021 | Q3 | -- | -- | -$0.34 | -$0.30 | -$0.04 |
| 08/12/2021 | Q2 | -- | -- | -$0.48 | -$0.34 | -$0.14 |
| 06/03/2021 | Q1 | -- | -- | -$0.40 | -$0.25 | -$0.15 |
| 12/31/2020 | Q4 | -- | -- | $0.01 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.61 | -- | -- |
NeuroPace Earnings Questions
-
How Much did NeuroPace Generate in Revenue Last Quarter?
NeuroPace reported $21.5M worth of top line sales in its most recent quarter.
-
Did NeuroPace Beat Earnings Last Quarter?
NeuroPace announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.22 per share.
-
Is NeuroPace Profitable?
NeuroPace reported $16.2M that represents $0.54 per share over the last quarter.
-
What is the Analyst Consensus for NeuroPace EPS Next Year?
NeuroPace's earnings are forecast to decrease from -$0.93 per share to -$0.84 per share next year representing a decrease of -9.92%.
-
When is NeuroPace's Earnings Date?
NeuroPace's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
